Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
9/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
9/10
₹14,502 Cr
30.36
6.17
46.1
0
21.76 %
--
0.26 %
309.4
62
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Lab
| 40.58 | -5.36 | 24.18 | 80.35 | 30.07 | 36.33 | 37.99 |
|
BSE Healthcare
| 40.88 | 1.39 | 15.22 | 58.71 | 19.27 | 29.74 | 12.49 |
|
BSE Mid Cap
| 31.48 | -0.39 | 2.08 | 51.14 | 23.30 | 28.64 | 17.76 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Lab
| 90.12 | -16.88 | 69.91 | 71.89 | -21.39 | -39.75 | 84.02 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
₹14,501.51 Cr
₹1,757.74 Cr
₹477.63 Cr
₹790.72 Cr
₹0.28 Cr
70.56%
High
₹954.00 - 2,158.80
₹2.00
7,60,11,696
BSE: 524742, NSE: CAPLIPOINT
Chennai, Tamil Nadu
www.caplinpoint.net
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections,... ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India. Read more
The total asset value of Caplin Point Laboratories Ltd stood at ₹ 2,697 Cr as on 30-Jun-24
The share price of Caplin Point Laboratories Ltd is ₹1,906.45 (NSE) and ₹1,907.80 (BSE) as of 11-Oct-2024 IST. Caplin Point Laboratories Ltd has given a return of 30.07% in the last 3 years.
Caplin Point Laboratories Ltd has a market capitalisation of ₹ 14,502 Cr as on 11-Oct-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Caplin Point Laboratories Ltd is 6.17 times as on 11-Oct-2024, a 10% discount to its peers’ median range of 6.84 times.
The P/E ratio of Caplin Point Laboratories Ltd is 30.36 times as on 11-Oct-2024, a 34% discount to its peers’ median range of 46.10 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Caplin Point Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Caplin Point Laboratories Ltd.
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
The prominent promoters of Caplin Point Laboratories Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
P VIJAYALAKSHMI |
24.71%
|
|
PAARTHIPAN C C |
18.64%
|
|
ASHOK GORKEY PARTHEEBAN |
11.91%
|
|
PARTHEEBAN VIVEK SIDDARTH |
11.84%
|
|
MAY INDIA PROPERTY PRIVATE LIMITED |
2.79%
|
The chairman of the company is C C Paarthipan, and the managing director is Sridhar Ganesan.
There is no promoter pledging in Caplin Point Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
61,183
|
|
|
47,138
|
|
|
42,006
|
|
|
41,819
|
| Caplin Point Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
21.76
|
|
Operating margin(%)
|
29.51
|
|
Net Margin(%)
|
26.32
|
|
Dividend yield(%)
|
0.26
|
Yes, TTM profit after tax of Caplin Point Laboratories Ltd was ₹478 Cr.
₹18.60
